Cancer mutation prediction using artificial intelligence
Dr Schmid talks to ecancertv at the 3rd ESTRO forum about the use of MRI in treatments of cervical cancer using brachytherapy.
He talks about the issues surrounding the availability of MRI in developing countries where there is a high incidence of cervical cancer.
Schmid also discusses the possible application of transrectal ultrasonography (TRUS) as an alternative method when MRI is not available.
Cancer mutation prediction using artificial intelligence
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting
SABCS 2023: Latest breast cancer diagnostics guidelines
Choosing Wisely in radiology Tanzania
Why tumour markers are not recommended as screening tests
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men
Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma
Tomosynthesis guided biopsy